AAMC
AZN icon

Asset Allocation & Management Company’s AstraZeneca AZN Stock Holding History

Asset Allocation & Management Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,237
Closed -$244K – 72
2026
Q1 		$244K Sell
1,237
-1
-0.1% -$193 0.09% 88
2025
Q4 		$228K Buy
+1,238
New +$217K 0.09% 88

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ISS
Intesa Sanpaolo SpA. Turin, Italy $2.92B AUM
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Asset Allocation & Management Company's AZN Position: Q2 2026 in Review

Asset Allocation & Management Company sold out of AstraZeneca (AZN) in Q2 2026, closing a stake of 1,237 shares — an estimated $244K sold.

Asset Allocation & Management Company first reported a position in AZN in Q4 2025 and held it in 2 quarters. The position peaked at $244K in Q1 2026. 655 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Asset Allocation & Management Company reported no remaining AstraZeneca position as of Q2 2026 after selling out during the quarter.
  • Asset Allocation & Management Company sold 1,237 AstraZeneca shares in Q2 2026, an estimated $244K.
  • Asset Allocation & Management Company first reported a position in AstraZeneca in Q4 2025 and held it in 2 quarters.
  • Asset Allocation & Management Company's AstraZeneca position peaked at $244K in Q1 2026.
  • 655 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Asset Allocation & Management Company's 13F filing for Q2 2026, filed 15 Jul 2026.